These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Generic vs. brand name drugs--defining and enforcing standards. Lasagna LC Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827 [No Abstract] [Full Text] [Related]
5. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300 [TBL] [Abstract][Full Text] [Related]
6. Benefits and liabilities of generic prescribing. Lee AM W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384 [No Abstract] [Full Text] [Related]
7. Determining drug equality. Hecht A FDA Consum; 1975 Nov; 9(9):18-20. PubMed ID: 10316633 [No Abstract] [Full Text] [Related]
8. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
9. How good are our drugs? Miller LC Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276 [No Abstract] [Full Text] [Related]
10. Multinational medicines--ensuring drug quality in an era of global manufacturing. Okie S N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686 [No Abstract] [Full Text] [Related]
11. New York State and drug lists: a history of confusion. Stetler CJ Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687 [No Abstract] [Full Text] [Related]
12. Major events during the generic drug investigations. Am Pharm; 1990 Jul; NS30(7):38-9. PubMed ID: 2363392 [No Abstract] [Full Text] [Related]
13. [Bioequivalence of solid drug preparation]. Ejima A Eisei Shikenjo Hokoku; 1982; (100):1-20. PubMed ID: 6897833 [No Abstract] [Full Text] [Related]
14. Who really assures prescription drug quality? J Indiana State Med Assoc; 1979 Mar; 72(3):164. PubMed ID: 422862 [No Abstract] [Full Text] [Related]
15. Some thoughts on the generic equivalency debate. Berry FB Med Times; 1971 Sep; 99(9):199-201. PubMed ID: 5170858 [No Abstract] [Full Text] [Related]
16. Tests for individual and population bioequivalence based on generalized p-values. McNally RJ; Iyer H; Mathew T Stat Med; 2003 Jan; 22(1):31-53. PubMed ID: 12486750 [TBL] [Abstract][Full Text] [Related]
17. United States Food and Drug Administration requirements for approval of generic drug products. Meyer MC J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846 [TBL] [Abstract][Full Text] [Related]
18. Clinical Endpoint Bioequivalence Studies Are Needed: A Perspective From Brand Drugs. Krishna R; Kesisoglou F Clin Pharmacol Ther; 2019 Feb; 105(2):298-300. PubMed ID: 30456848 [No Abstract] [Full Text] [Related]
19. Generic equivalency: does it exist? Payne RJ Med Ann Dist Columbia; 1969 Sep; 38(9):490-2. PubMed ID: 5259629 [No Abstract] [Full Text] [Related]